Gene Knockdown Market Report

Global and Region Gene Knockdown Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：199
  • REPORT CODE：GMM991373
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Gene Knockdown market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gene Knockdownmarket, defines the market attractiveness level of Gene Knockdown market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gene Knockdown industry, describes the types of Gene Knockdown market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene Knockdown market and the development prospects and opportunities of Gene Knockdown industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene Knockdown market in Chapter 13.

    By Player:

    • Invitrogen (US)

    • Novus Biologicals (US)

    • siTOOLs Biotech (Germany)

    • Agilent Technologies (US)(Taiwan)

    • Cell Signaling Technology (US)

    • Creative Biomart (US)

    • Bio-Rad (US)

    • OriGene (US)

    • Selleck Chemicals (US)

    • Santa Cruz Biotechnology (US)

    • GeneCopoeia (US)

    • Sigma-Aldrich (US)

    • BioVision (US)

    • EMD Millipore (US)

    • Abnova

    • MyBioSource (US)

    • Qiagen (Germany)

    By Type:

    • siRNA

    • shRNA

    • Other

    By End-User:

    • Medical

    • Bioengineering

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gene Knockdown Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gene Knockdown Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gene Knockdown Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gene Knockdown Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gene Knockdown Market Analysis and Outlook to 2022

    • 7.1 Global Gene Knockdown Consumption (2017-2022)

    • 7.2 United States Gene Knockdown Consumption (2017-2022)

    • 7.3 Europe Gene Knockdown Consumption (2017-2022)

    • 7.4 China Gene Knockdown Consumption (2017-2022)

    • 7.5 Japan Gene Knockdown Consumption (2017-2022)

    • 7.6 India Gene Knockdown Consumption (2017-2022)

    • 7.7 South Korea Gene Knockdown Consumption (2017-2022)

    8 Region and Country-wise Gene Knockdown Market Analysis and Outlook to 2028

    • 8.1 Global Gene Knockdown Consumption Forecast (2022-2028)

    • 8.2 United States Gene Knockdown Consumption Forecast (2022-2028)

    • 8.3 Europe Gene Knockdown Consumption Forecast (2022-2028)

    • 8.4 China Gene Knockdown Consumption Forecast (2022-2028)

    • 8.5 Japan Gene Knockdown Consumption Forecast (2022-2028)

    • 8.6 India Gene Knockdown Consumption Forecast (2022-2028)

    • 8.7 South Korea Gene Knockdown Consumption Forecast (2022-2028)

    9 Global Gene Knockdown Market Outlook by Types and Applications to 2022

    • 9.1 Global Gene Knockdown Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global siRNA Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global shRNA Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gene Knockdown Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Medical Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Bioengineering Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Gene Knockdown Market Outlook by Types and Applications to 2028

    • 10.1 Global Gene Knockdown Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global siRNA Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global shRNA Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gene Knockdown Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Medical Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Bioengineering Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gene Knockdown Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gene Knockdown Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gene Knockdown Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gene Knockdown Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gene Knockdown Market Competitive Analysis

    • 14.1 Invitrogen (US)

      • 14.1.1 Invitrogen (US) Company Details

      • 14.1.2 Invitrogen (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Invitrogen (US) Gene Knockdown Product and Service

    • 14.2 Novus Biologicals (US)

      • 14.2.1 Novus Biologicals (US) Company Details

      • 14.2.2 Novus Biologicals (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novus Biologicals (US) Gene Knockdown Product and Service

    • 14.3 siTOOLs Biotech (Germany)

      • 14.3.1 siTOOLs Biotech (Germany) Company Details

      • 14.3.2 siTOOLs Biotech (Germany) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 siTOOLs Biotech (Germany) Gene Knockdown Product and Service

    • 14.4 Agilent Technologies (US)(Taiwan)

      • 14.4.1 Agilent Technologies (US)(Taiwan) Company Details

      • 14.4.2 Agilent Technologies (US)(Taiwan) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Agilent Technologies (US)(Taiwan) Gene Knockdown Product and Service

    • 14.5 Cell Signaling Technology (US)

      • 14.5.1 Cell Signaling Technology (US) Company Details

      • 14.5.2 Cell Signaling Technology (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Cell Signaling Technology (US) Gene Knockdown Product and Service

    • 14.6 Creative Biomart (US)

      • 14.6.1 Creative Biomart (US) Company Details

      • 14.6.2 Creative Biomart (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Creative Biomart (US) Gene Knockdown Product and Service

    • 14.7 Bio-Rad (US)

      • 14.7.1 Bio-Rad (US) Company Details

      • 14.7.2 Bio-Rad (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bio-Rad (US) Gene Knockdown Product and Service

    • 14.8 OriGene (US)

      • 14.8.1 OriGene (US) Company Details

      • 14.8.2 OriGene (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 OriGene (US) Gene Knockdown Product and Service

    • 14.9 Selleck Chemicals (US)

      • 14.9.1 Selleck Chemicals (US) Company Details

      • 14.9.2 Selleck Chemicals (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Selleck Chemicals (US) Gene Knockdown Product and Service

    • 14.10 Santa Cruz Biotechnology (US)

      • 14.10.1 Santa Cruz Biotechnology (US) Company Details

      • 14.10.2 Santa Cruz Biotechnology (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Santa Cruz Biotechnology (US) Gene Knockdown Product and Service

    • 14.11 GeneCopoeia (US)

      • 14.11.1 GeneCopoeia (US) Company Details

      • 14.11.2 GeneCopoeia (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 GeneCopoeia (US) Gene Knockdown Product and Service

    • 14.12 Sigma-Aldrich (US)

      • 14.12.1 Sigma-Aldrich (US) Company Details

      • 14.12.2 Sigma-Aldrich (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Sigma-Aldrich (US) Gene Knockdown Product and Service

    • 14.13 BioVision (US)

      • 14.13.1 BioVision (US) Company Details

      • 14.13.2 BioVision (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 BioVision (US) Gene Knockdown Product and Service

    • 14.14 EMD Millipore (US)

      • 14.14.1 EMD Millipore (US) Company Details

      • 14.14.2 EMD Millipore (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 EMD Millipore (US) Gene Knockdown Product and Service

    • 14.15 Abnova

      • 14.15.1 Abnova Company Details

      • 14.15.2 Abnova Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Abnova Gene Knockdown Product and Service

    • 14.16 MyBioSource (US)

      • 14.16.1 MyBioSource (US) Company Details

      • 14.16.2 MyBioSource (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 MyBioSource (US) Gene Knockdown Product and Service

    • 14.17 Qiagen (Germany)

      • 14.17.1 Qiagen (Germany) Company Details

      • 14.17.2 Qiagen (Germany) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Qiagen (Germany) Gene Knockdown Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gene Knockdown

    • Figure Gene Knockdown Picture

    • Table Global Gene Knockdown Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gene Knockdown Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gene Knockdown Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gene Knockdown Consumption by Country (2017-2022)

    • Figure United States Gene Knockdown Consumption and Growth Rate (2017-2022)

    • Table Europe Gene Knockdown Consumption and Growth Rate (2017-2022)

    • Figure China Gene Knockdown Consumption and Growth Rate (2017-2022)

    • Figure Japan Gene Knockdown Consumption and Growth Rate (2017-2022)

    • Figure India Gene Knockdown Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gene Knockdown Consumption and Growth Rate (2017-2022)

    • Figure Global Gene Knockdown Consumption Forecast by Country (2022-2028)

    • Figure United States Gene Knockdown Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gene Knockdown Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gene Knockdown Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gene Knockdown Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gene Knockdown Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gene Knockdown Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global siRNA Consumption and Growth Rate (2017-2022)

    • Figure Global shRNA Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Consumption and Growth Rate (2017-2022)

    • Figure Global Bioengineering Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global siRNA Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global shRNA Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bioengineering Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gene Knockdown Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gene Knockdown Export by Region (Top 5 Countries) (2017-2028)

    • Table Invitrogen (US) (Foundation Year, Company Profile and etc.)

    • Table Invitrogen (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Invitrogen (US) Gene Knockdown Product and Service

    • Table Novus Biologicals (US) (Foundation Year, Company Profile and etc.)

    • Table Novus Biologicals (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novus Biologicals (US) Gene Knockdown Product and Service

    • Table siTOOLs Biotech (Germany) (Foundation Year, Company Profile and etc.)

    • Table siTOOLs Biotech (Germany) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table siTOOLs Biotech (Germany) Gene Knockdown Product and Service

    • Table Agilent Technologies (US)(Taiwan) (Foundation Year, Company Profile and etc.)

    • Table Agilent Technologies (US)(Taiwan) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies (US)(Taiwan) Gene Knockdown Product and Service

    • Table Cell Signaling Technology (US) (Foundation Year, Company Profile and etc.)

    • Table Cell Signaling Technology (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cell Signaling Technology (US) Gene Knockdown Product and Service

    • Table Creative Biomart (US) (Foundation Year, Company Profile and etc.)

    • Table Creative Biomart (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Creative Biomart (US) Gene Knockdown Product and Service

    • Table Bio-Rad (US) (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad (US) Gene Knockdown Product and Service

    • Table OriGene (US) (Foundation Year, Company Profile and etc.)

    • Table OriGene (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table OriGene (US) Gene Knockdown Product and Service

    • Table Selleck Chemicals (US) (Foundation Year, Company Profile and etc.)

    • Table Selleck Chemicals (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Selleck Chemicals (US) Gene Knockdown Product and Service

    • Table Santa Cruz Biotechnology (US) (Foundation Year, Company Profile and etc.)

    • Table Santa Cruz Biotechnology (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Santa Cruz Biotechnology (US) Gene Knockdown Product and Service

    • Table GeneCopoeia (US) (Foundation Year, Company Profile and etc.)

    • Table GeneCopoeia (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table GeneCopoeia (US) Gene Knockdown Product and Service

    • Table Sigma-Aldrich (US) (Foundation Year, Company Profile and etc.)

    • Table Sigma-Aldrich (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sigma-Aldrich (US) Gene Knockdown Product and Service

    • Table BioVision (US) (Foundation Year, Company Profile and etc.)

    • Table BioVision (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioVision (US) Gene Knockdown Product and Service

    • Table EMD Millipore (US) (Foundation Year, Company Profile and etc.)

    • Table EMD Millipore (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table EMD Millipore (US) Gene Knockdown Product and Service

    • Table Abnova (Foundation Year, Company Profile and etc.)

    • Table Abnova Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abnova Gene Knockdown Product and Service

    • Table MyBioSource (US) (Foundation Year, Company Profile and etc.)

    • Table MyBioSource (US) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table MyBioSource (US) Gene Knockdown Product and Service

    • Table Qiagen (Germany) (Foundation Year, Company Profile and etc.)

    • Table Qiagen (Germany) Gene Knockdown Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen (Germany) Gene Knockdown Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US